EIB, Angelini Ventures team up to pump €150 million into European biotech, digital health startups
Angelini Ventures has already invested €125 million in 22 startups
Angelini Ventures has already invested €125 million in 22 startups
This is the first time in history that an NDA for a New Chemical Entity (NCE) from an Indian pharmaceutical company has been filed and accepted by the USFDA
Sac-TMT is a novel human TROP2 ADC with proprietary intellectual property, targeting advanced solid tumors
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
The formulation is backed by over 80 clinical trials and 200 scientific publications
The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability
The new company aims to transform cutting-edge, highly scalable technologies into innovative drug discovery platforms
Panacea Biotec receives acceptance from CMSS for supply of bOPV
Liothyronine tablets will be manufactured at Zydus' plant in Ahmedabad SEZ
Subscribe To Our Newsletter & Stay Updated